Skip to main content
. 2007 Mar;2(1):17–32. doi: 10.2147/ciia.2007.2.1.17

Figure 1.

Figure 1

Percentage of patients with moderate to moderately severe AD showing clinically relevant improvements on the ADAS-cog after 52 weeks.

Notes: *p < 0.05 versus original placebo group; **p = 0.116 versus original placebo group.

Abbreviations: AD, Alzheimer’s disease; ADAS-cog, Alzheimer’s Disease Assessment Scale–Cognitive section.